Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis

類似資料

• Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
  著者:: Madsen, Bjørn Stæhr, 等
  出版事項: (2018)
• Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
  著者:: Marta Carol, 等
  出版事項: (2022-01-01)
• Prolonged albumin administration in patients with decompensated cirrhosis: the amount makes the difference
  著者:: Tufoni, Manuel, 等
  出版事項: (2019)
• Future therapy of portal hypertension in liver cirrhosis – a guess
  著者:: Sauerbruch, Tilman, 等
  出版事項: (2014)
• Pre-primary and Primary Prophylaxis of Variceal Hemorrhage
  著者:: Sauerbruch, Tilman, 等
  出版事項: (2013)